Clinical Trial Update: Safety Study of A-101 Topical Solution for the Treatment of Common Warts [Phase 3]

View source ↗

Summary

A Phase 3 safety study of A-101 topical solution for common warts has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Common Wart

Drugs mentioned

• A-101 Topical Solution

Snippet

Sponsor: Aclaris Therapeutics, Inc. | Conditions: Common Wart | Phase 3 | Status: COMPLETED | Results posted: 2020-11-23